VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 34 filers reported holding VIRIDIAN THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $5,329,807 | -12.9% | 209,505 | 0.0% | 1.15% | -45.6% |
| Q4 2022 | $6,119,641 | +42.4% | 209,505 | 0.0% | 2.11% | +36.4% |
| Q3 2022 | $4,297,000 | +77.3% | 209,505 | 0.0% | 1.55% | +102.4% |
| Q2 2022 | $2,424,000 | -37.4% | 209,505 | 0.0% | 0.76% | -8.3% |
| Q1 2022 | $3,874,000 | -6.5% | 209,505 | 0.0% | 0.83% | +44.8% |
| Q4 2021 | $4,142,000 | +20.2% | 209,505 | 0.0% | 0.58% | +41.2% |
| Q3 2021 | $3,446,000 | -10.1% | 209,505 | 0.0% | 0.41% | +2.5% |
| Q2 2021 | $3,832,000 | +9.5% | 209,505 | 0.0% | 0.40% | -38.4% |
| Q1 2021 | $3,501,000 | +1.6% | 209,505 | 0.0% | 0.65% | -16.4% |
| Q4 2020 | $3,446,000 | – | 209,505 | – | 0.77% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ally Bridge Group (NY) LLC | 680,768 | $11,376,000 | 2.18% |
| COMMODORE CAPITAL LP | 185,781 | $3,104,000 | 1.24% |
| Ghost Tree Capital, LLC | 300,000 | $5,013,000 | 1.18% |
| Logos Global Management LP | 550,000 | $9,191,000 | 0.90% |
| Atlas Venture Advisors, Inc. | 209,505 | $3,501,000 | 0.65% |
| BVF INC/IL | 463,504 | $7,745,000 | 0.29% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 27,586 | $461,000 | 0.25% |
| Fairmount Funds Management LLC | 35,092 | $581,000 | 0.24% |
| Soleus Capital Management, L.P. | 67,685 | $1,131,000 | 0.20% |
| Cormorant Asset Management, LP | 459,144 | $7,672,000 | 0.17% |